Name | Relationship | Address | Signature | Signature date | CIK |
---|---|---|---|---|---|
Erickson Gayn | President and CEO, Director | C/O AEHR TEST SYSTEMS, 400 KATO TERRACE, FREMONT | /s/Chris Siu, Attorney-in-Fact | 2025-10-14 | 0001364097 |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | AEHR | Common Stock | Tax liability | -$96.7K | -3.79K | -1.41% | $25.52 | 265K | Oct 13, 2025 | Direct | F1, F2 |
transaction | AEHR | Common Stock | Tax liability | -$94.1K | -3.45K | -1.3% | $27.29 | 262K | Oct 14, 2025 | Direct | F1, F2 |
holding | AEHR | Common Stock | 292K | Oct 13, 2025 | By Trust | F3 |
Id | Content |
---|---|
F1 | Represents shares that were withheld to satisfy tax withholding obligations upon vesting of restricted stock units and restricted shares. This does not represent a sale by the Reporting Person. |
F2 | The amount reported includes shares subject to unvested restricted stock units and unvested restricted shares. |
F3 | RSA with vesting schedule |